doi: 10.1177/1367493510385020
Your trusted source for comprehensive peptide dosage protocols and research information
It has become a significant public health concern, with a global prevalence rate of 4.4% (Monroe and Harkness, 2022
Papaioannou A, Liakopoulou A, Papoulis D, Gianni E, Gkolfi P, Zygouri E, et al
It is imperative for professionals and researchers alike to employ this compound in compliance with proper handling and storage protocols to ensure optimal results
Who should avoid GHK-Cu entirely Wilson's disease or any copper metabolism disorder Active malignancy until more evidence exists Pregnancy and breastfeeding Known copper sensitivity Anyone unable to maintain sterile technique for injection When unsure, talk to us before starting anything